Literature DB >> 15254165

Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.

Kathie-Anne Walters1, Michael A Joyce, William R Addison, Karl P Fischer, D Lorne J Tyrrell.   

Abstract

Superinfection exclusion is the phenomenon whereby a virus prevents the subsequent infection of an already infected host cell. The Pekin duck hepatitis B virus (DHBV) model was used to investigate superinfection exclusion in hepadnavirus infections. Superinfection exclusion was shown to occur both in vivo and in vitro with a genetically marked DHBV, DHBV-ClaI, which was unable to establish an infection in either DHBV-infected ducklings or DHBV-infected primary duck hepatocytes (PDHs). In addition, exclusion occurred in vivo even when the second virus had a replicative advantage. Superinfection exclusion appears to be restricted to DHBV, as adenovirus, herpes simplex virus type 1, and vesicular stomatitis virus were all capable of efficiently infecting DHBV-infected PDHs. Exclusion was dependent on gene expression by the original infecting virus, since UV-irradiated DHBV was unable to mediate the exclusion of DHBV-ClaI. Using recombinant adenoviruses expressing DHBV proteins, we determined that the large surface antigen mediated exclusion. The large surface antigen is known to cause down-regulation of a DHBV receptor, carboxypeptidase D (CPD). Receptor down-regulation is a mechanism of superinfection exclusion seen in other viral infections, and so it was investigated as a possible mechanism of DHBV-mediated exclusion. However, a mutant large surface antigen which did not down-regulate CPD was still capable of inhibiting DHBV infection of PDHs. In addition, exclusion of DHBV-ClaI did not correlate with a decrease in CPD levels. Finally, virus binding assays and confocal microscopy analysis of infected PDHs indicated that the block in infection occurs after internalization of the second virus. We suggest that superinfection exclusion may result from the role of the L surface antigen as a regulator of intracellular trafficking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254165      PMCID: PMC446106          DOI: 10.1128/JVI.78.15.7925-7937.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Cost-effective one-step PCR amplification of cystic fibrosis delta F508 fragment in a single cell for preimplantation genetic diagnosis.

Authors:  Y H Tsai
Journal:  Prenat Diagn       Date:  1999-11       Impact factor: 3.050

3.  Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes.

Authors:  U Schultz; J Summers; P Staeheli; F V Chisari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Authors:  H McClary; R Koch; F V Chisari; L G Guidotti
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Cellular receptor traffic is essential for productive duck hepatitis B virus infection.

Authors:  K M Breiner; H Schaller
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes.

Authors:  U Schultz; F V Chisari
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection.

Authors:  U Protzer; M Nassal; P W Chiang; M Kirschfink; H Schaller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Carboxypeptidase D is an avian hepatitis B virus receptor.

Authors:  S Tong; J Li; J R Wands
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Kinetics of early molecular events in duck hepatitis B virus replication in primary duck hepatocytes.

Authors:  M Qiao; C A Scougall; A Duszynski; C J Burrell
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

10.  Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.

Authors:  R J Lenhoff; C A Luscombe; J Summers
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

View more
  25 in total

1.  Global changes in cellular gene expression during bacteriophage PRD1 infection.

Authors:  Minna M Poranen; Janne J Ravantti; A Marika Grahn; Rashi Gupta; Petri Auvinen; Dennis H Bamford
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 2.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.

Authors:  Bernadette Schmid; Christine Rösler; Michael Nassal
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 4.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection.

Authors:  Natalia Freitas; Tetyana Lukash; Louise Rodrigues; Sam Litwin; Bhaskar V Kallakury; Stephan Menne; Severin O Gudima
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

6.  Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks.

Authors:  Natalia Freitas; Tetyana Lukash; Megan Dudek; Sam Litwin; Stephan Menne; Severin O Gudima
Journal:  Virus Res       Date:  2015-05-12       Impact factor: 3.303

7.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 8.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

9.  A viral protein mediates superinfection exclusion at the whole-organism level but is not required for exclusion at the cellular level.

Authors:  María Bergua; Mark P Zwart; Choaa El-Mohtar; Turksen Shilts; Santiago F Elena; Svetlana Y Folimonova
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

10.  Zinc finger proteins designed to specifically target duck hepatitis B virus covalently closed circular DNA inhibit viral transcription in tissue culture.

Authors:  Kimberley A Zimmerman; Karl P Fischer; Michael A Joyce; D Lorne J Tyrrell
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.